Comprehensive panels 

Optimize therapeutic outcomes

Research shows a significant percentage of patients possess genetic variants that impact therapeutic response, leading to a lack of treatment efficacy or treatment-related toxicity. Establishing a patient’s genetic profile through pharmacogenomic testing allows physicians to individualize treatment by selecting medications that optimize therapeutic efficacy while avoiding harmful drug reactions.

Our psychotropic and focused pharmacogenomic panels examine dozens of alleles on multiple genes to assess for known drug phenotype associations and identify variations associated with treatment response.

Comprehensive panels Test menu

Comprehensive panels

Key testing


  1. Wang L, Scherer SE, Bielinski SJ, et al. Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study. Genet Med. 2022;24(5):1062-1072. doi:10.1016/j.gim.2022.01.022

Fill out the form below and one of our specialists will be in touch.